Lilly is launching a new web portal which it hopes will attract drug discovery researchers with promising new compounds. The …
Pharmafocus presents a round-up of developments in the contract research sector, including CBI's acquisition of a peptide specialist, MDS Pharma …
Novartis is ready to press ahead with clinical trials of its candidate vaccine against influenza (A)H1N1, having completed manufacturing of …
The UK has always been one of the world's leaders in drug discovery, with around half of all major medicines …
Irish contract research organisation Icon will manage clinical trial set-up and management for Lilly's European trials in a deal that …
Patients with early stage Alzheimer's disease will still be denied access to drug treatment after NICE decided to retain its …
The new health secretary Andy Burnham has promised a 'deep clean' of the NHS' priorities, with a further move away …
Moves to make it easier for biosimilars to be approved in the US are gaining momentum.The pharma industry has conceded …
Schering-Plough has opened a new pharmaceutical manufacturing facility in Oss, the Netherlands, to help meet demand for the drugmakers' injectable …
The Department of Health has insisted there will be no "material change" to the UK's preparations for swine flu. The …
Government anti-smoking measures are to receive a boost with the provision of a £2.5 million grant to help smokers kick …

The deal gives the Roche-owned biotech development and marketing rights to Bayhill’s molecule BHT-3021, which is currently in phase I/II …
The big pharma model is broken, and one of the ways drug development companies are going to fix it is …
The NHS is hurtling towards the most severe financial shortfall of its history, and faces an austere future of cutting …
Contract research organisation Kendle has opened up new offices in Malaysia, Thailand and the Philippines as part of a continued …
Despite the pharmaceutical industry's evolving business model in response to growing regulatory constraints, the sector is facing unprecedented challenges caused …
Sanofi-Aventis will pay 30 million euros (£26 million) for a manufacturing plant in Germany operated by Pfizer in a deal …
The Pharmaceutical Marketing Society is to showcase the best in digital media across the pharma and healthcare industry at a …